Neuroflow
Latest round
- Series C
Last raised
- Jul 2022
Total raised
- $33M
Investors
- 10
About Neuroflow
Neuroflow, Inc.Founded in 2017 and headquartered in Philadelphia, US, Neuroflow, Inc. specializes in digital behavioral health solutions. The company was co-founded by Adam Pardes, Christopher Molaro, and Jan Burgstaller, with Christopher Molaro currently serving as CEO.S.NeuroFlow provides a comprehensive digital platform designed to enhance behavioral health care through advanced data analytics and measurement infrastructure. The core offerings include tools that identify and stratify behavioral health risks within populations, allowing health payors, systems, and the federal government to better manage care. NeuroFlow’s technology facilitates remote assessments, thereby saving clinical time and improving patient engagement by activating individuals based on their specific acuity levels. This platform serves a diverse customer base, including health plans, healthcare systems, accountable care organizations (ACOs), integrated delivery networks (IDNs), federal agencies, and behavioral health providers.Revenue generation for NeuroFlow primarily comes from partnerships and subscriptions with health care providers and organizations. Clients engage in service agreements that allow them to access NeuroFlow’s platform, which includes features for monitoring client progress and evaluating care outcomes. The structure typically involves B2B transactions where health systems and payors subscribe to the platform for ongoing use, integrating it into their care management strategies. Pricing models may include tiered subscription plans based on user volume or the breadth of services utilized, reflecting the specific needs of each client.Neuroflow's strategy for future growth includes plans to launch new products aimed at enhancing user engagement and extending their service offerings. The company is also focusing on expanding into new markets, particularly targeting regions across North America by the end of 2024.
Who invested in Neuroflow
10 investors across 3 rounds
See all investors in Neuroflow
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neuroflow
Who invested in Neuroflow?
Neuroflow has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neuroflow raised?
Neuroflow has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Neuroflow last raise money?
Neuroflow's most recent round on record is a Series C, in Jul 2022.
What does Neuroflow do?
Neuroflow is a healthcare it company.
Where is Neuroflow headquartered?
Neuroflow is headquartered in Philadelphia, US.
Which VCs invest in companies like Neuroflow?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Neuroflow's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like Neuroflow? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.